The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bayer; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Bayer; Roche; Sanofi
 
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Kite/Gilead; Miltenyi Biotec; MOLOGEN; MSD; Novartis; Roche
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Kite/Gilead; Miltenyi Biotec; MOLOGEN; MSD; Novartis; Roche
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Kite/Gilead; Miltenyi Biotec; MOLOGEN; MSD; Novartis; Roche
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Kite/Gilead; Miltenyi Biotec; MOLOGEN; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Astellas Pharma; Kite/Gilead; Miltenyi Biotec; MOLOGEN; MSD; Novartis; Roche
Implementing a novel method to estimate the "Burden of Therapy" (BOTh) for patients with metastatic pancreatic cancer treated with gemcitabine plus afatinib vs. gemcitabine in the AIO ACCEPT trial.
 
Michael Haas
Research Funding - Boehringer Ingelheim (Inst)
 
Ayad Abdul-Ahad
Consulting or Advisory Role - Roche UK
 
Robert Snijder
Employment - Astellas Pharma
 
Dirk Thomas Waldschmidt
Speakers' Bureau - AstraZeneca; Bayer Health; Bristol-Myers Squibb; Celgene; Eisai; Falk Pharma; Ipsen; Novartis; Roche; SERVIER; Shire; Sirtex Medical
Travel, Accommodations, Expenses - Bayer Health; Celgene; Ipsen; Novartis; Sirtex Medical
 
Michael Stahl
Honoraria - Amgen; Celgene; Lilly; Merck Serono; MSD; Pfizer; Sanofi; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; MSD; Shire
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Serono; MSD
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Aurikamed; Baxalta; BOVita; Bristol-Myers Squibb; Celgene; iomedico; Lilly; MCI Group; med publico; Merck Serono; MSD; Pfizer; Promedior; Roche; Sanofi/Aventis; SERVIER; Shire
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bristol-Myers Squibb; Celgene; Merck Serono; MSD; Onkowissen; Pfizer; Pierre Fabre; Roche; Sanofi/Aventis; SERVIER
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Georgius Agricola Stiftung Ruhr (Inst); Ipsen (Inst); Lilly (Inst); Ludwig Maximilian University of Munich (Inst); MOLOGEN (Inst); Pharma Consulting Group AB (Inst); PPD Global (Inst); Roche (Inst); Servier (Inst); Syneed Medidata (Inst); University of Cologne (Inst); University of Erlangen-Nuremberg (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; Ipsen; MCI Group; Merck Serono; MSD; Onkowissen; Pierre Fabre; Roche; Servier
 
Jens Freiberg-Richter
No Relationships to Disclose
 
Florian Kaiser
No Relationships to Disclose
 
Stephan Kanzler
No Relationships to Disclose
 
Norbert Frickhofen
Research Funding - Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Roche Pharma AG (Inst)
 
Thomas Seufferlein
Honoraria - Amgen; Baxalta; Bayer Schering Pharma; Celgene; Falk Foundation; Halozyme; Merck Serono; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Baxalta; Bayer; Celgene; Halozyme; Merck Serono; Roche/Genentech; Shire
Research Funding - Celgene; Sanofi
Travel, Accommodations, Expenses - Celgene; Merck Serono; Roche; Sanofi; SERVIER
 
Tobias Nicolaas Dechow
No Relationships to Disclose
 
Rolf Mahlberg
Employment - Klinikum Mutterhaus der Borromaeerinnen
Honoraria - Amgen; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Merck; Pfizer
 
Peter Malfertheiner
Consulting or Advisory Role - Bayer Health; Danone; Mayoly-Spindler
Speakers' Bureau - Alfasigma; Bayer; Falk Foundation; Phantom Pharmaceuticals; Takeda
 
Gerald Illerhaus
No Relationships to Disclose
 
Stefan Kubicka
No Relationships to Disclose
 
Swantje Held
No Relationships to Disclose
 
Stefan Hubert Boeck
Honoraria - Celgene; SERVIER
 
Michael von Bergwelt-Baildon
No Relationships to Disclose
 
Volker Heinemann
Honoraria - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Halozyme; Merck; MSD; MSD Oncology; Roche; Sanofi; SERVIER; Sirtex Medical
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Roche (Inst); Servier (Inst); Shire (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER; Shire; Sirtex Medical